Jecko V. Thachil

Jecko V. Thachil's AcademicInfluence.com Rankings

Jecko V. Thachil

Philosophy

#5630

World Rank

#8489

Historical Rank

Logic

#2866

World Rank

#3936

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jecko V. Thachil's Degrees

Masters Medicine University of Kerala
Doctorate Internal Medicine University of Kerala
PhD Haematology University of Manchester

Why Is Jecko V. Thachil Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jecko V. Thachil's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 (2020) (1544)
Coagulation abnormalities and thrombosis in patients with COVID-19 (2020) (1109)
Guidelines for the diagnosis and management of disseminated intravascular coagulation (2009) (752)
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 (2020) (498)
The versatile heparin in COVID‐19 (2020) (374)
Coagulopathy of Coronavirus Disease 2019 (2020) (370)
The unique characteristics of COVID-19 coagulopathy (2020) (342)
Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines (2013) (304)
Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation (2019) (283)
Coagulopathy in COVID‐19 (2020) (268)
New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey (2017) (204)
Effects of the COVID-19 pandemic on supply and use of blood for transfusion (2020) (169)
Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. (2009) (144)
Vitamin B12 deficiency - A 21st century perspective . (2015) (133)
DAMP and DIC: The role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC. (2016) (121)
Management of surgical patients receiving anticoagulation and antiplatelet agents (2008) (111)
Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma‐shock (COT/ACOTS) (2013) (110)
Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects (2016) (109)
Human CRP Defends against the Toxicity of Circulating Histones (2013) (104)
The effects of cancer and cancer therapy on male fertility. (1981) (104)
Catheter-related thrombosis: A practical approach (2016) (100)
British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding (2018) (98)
Practical guidance for the management of adults with immune thrombocytopenia during the COVID‐19 pandemic (2020) (96)
Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH (2016) (96)
SARS-2 Coronavirus–Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism? (2020) (94)
Anticoagulation in chronic kidney disease patients—the practical aspects (2014) (94)
Whole genome sequencing of a sporadic primary immunodeficiency cohort (2018) (92)
Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. (2015) (91)
A proposal for staging COVID‐19 coagulopathy (2020) (84)
Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension (2017) (84)
Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH (2018) (80)
Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation (2020) (78)
Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy—Either, Neither, or Both (2020) (76)
Perioperative management of patients on new oral anticoagulants (2014) (76)
Proposal of the Definition for COVID-19-Associated Coagulopathy (2021) (72)
How do we approach thrombocytopenia in critically ill patients? (2017) (71)
Anticoagulant therapy for sepsis‐associated disseminated intravascular coagulation: the view from Japan (2014) (71)
What do monitoring platelet counts in COVID‐19 teach us? (2020) (66)
Thrombomodulin in disseminated intravascular coagulation and other critical conditions—a multi-faceted anticoagulant protein with therapeutic potential (2019) (65)
Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia (2017) (62)
Towards standardization of clot waveform analysis and recommendations for its clinical applications (2013) (59)
The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation] (2012) (56)
How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults (2018) (55)
Differential diagnoses for sepsis‐induced disseminated intravascular coagulation: communication from the SSC of the ISTH (2019) (55)
Supportive management strategies for disseminated intravascular coagulation (2015) (54)
ISTH DIC subcommittee communication on anticoagulation in COVID‐19 (2020) (52)
Platelets in Inflammatory Disorders: A Pathophysiological and Clinical Perspective (2015) (51)
Harmonisation of D-dimer - A call for action. (2016) (50)
Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan (2016) (50)
COVID‐19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry—Communication from the ISTH SSC for Women’s Health (2020) (48)
Venous thromboembolism in multiple myeloma – choice of prophylaxis, role of direct oral anticoagulants and special considerations (2018) (48)
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients (2020) (47)
Management of cancer‐associated disseminated intravascular coagulation: guidance from the SSC of the ISTH (2015) (46)
Relevance of clotting tests in liver disease (2008) (46)
Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity (2016) (45)
Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality (2020) (45)
ISTH guidelines for antithrombotic treatment in COVID‐19 (2022) (45)
D-Dimer Testing: Laboratory Aspects and Current Issues. (2017) (44)
Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes (2018) (43)
The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease (2021) (43)
A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor. (2016) (41)
The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases. (2019) (41)
A re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH (2018) (41)
Understanding the COVID‐19 coagulopathy spectrum (2020) (40)
Exocrine function of testis with germinal testicular tumour. (1983) (39)
Defining trauma‐induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTH (2020) (39)
Potential diagnostic markers for disseminated intravascular coagulation of sepsis. (2016) (38)
Preservation techniques for human semen. (1981) (37)
Appropriate use of D-dimer in hospital patients. (2010) (35)
All those D‐dimers in COVID‐19 (2020) (35)
Cerebral venous thrombosis-a primer for the haematologist. (2015) (35)
Disseminated intravascular coagulation – new pathophysiological concepts and impact on management (2016) (35)
Granulocytic sarcoma - a rare presentation of a breast lump. (2007) (34)
The use of direct oral anticoagulants in chronic kidney disease (2018) (34)
The need for accurate D‐dimer reporting in COVID‐19: Communication from the ISTH SSC on fibrinolysis (2020) (32)
Iron deficiency without anaemia: a diagnosis that matters. (2021) (32)
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC (2018) (32)
Hypoxia—An overlooked trigger for thrombosis in COVID‐19 and other critically ill patients (2020) (31)
The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis (2011) (31)
SARS-CoV-2 Vaccination and Immune Thrombocytopenia in de novo and pre-existing ITP patients (2021) (30)
LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia (2016) (29)
Antiplatelet therapy - a summary for the general physicians. (2016) (29)
Rituximab‐induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia (2006) (28)
De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures (2018) (26)
Type and dose of heparin in Covid‐19: Reply (2020) (26)
The use of fondaparinux in pregnancy (2015) (24)
Disseminated intravascular coagulation in paediatrics (2016) (24)
The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation. (2015) (24)
Comparison of disseminated intravascular coagulation in trauma with coagulopathy of trauma/acute coagulopathy of trauma‐shock (2012) (24)
Reintroduction of anti‐thrombotic therapy after a gastrointestinal haemorrhage: if and when? (2017) (24)
Thromboembolic events are not uncommon in patients with immune thrombocytopenia (2010) (24)
Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis (2020) (23)
The Elusive Diagnosis of Disseminated Intravascular Coagulation: Does a Diagnosis of DIC Exist Anymore? (2019) (23)
Management of disseminated intravascular coagulation: a survey of the International Society on Thrombosis and Haemostasis. (2015) (23)
Current concepts in the management of disseminated intravascular coagulation. (2012) (22)
Disseminated Intravascular Coagulation: A Practical Approach (2016) (22)
The protective rather than prothrombotic fibrinogen in COVID‐19 and other inflammatory states (2020) (21)
The newer direct oral anticoagulants: a practical guide. (2014) (21)
The development of sarcoidosis with the use of alemtuzumab – clues to T‐cell immune reconstitution (2007) (21)
Management of cancer‐associated disseminated intravascular coagulation: guidance from the SSC of the ISTH: reply (2015) (20)
A comprehensive targeted next‐generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia (2018) (20)
Haematological Diseases in the Tropics (2013) (20)
DIC in obstetrics: Diagnostic score, highlights in management, and international registry‐communication from the DIC and Women's Health SSCs of the International Society of Thrombosis and Haemostasis (2019) (20)
Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation (2019) (20)
Laboratory haemostasis monitoring in COVID‐19 (2020) (20)
Anemia--the overlooked factor in bleeding related to liver disease. (2011) (19)
Lessons from acute pancreatitis-induced thrombotic thrombocytopenic purpura. (2009) (18)
The prothrombotic potential of platelet factor 4. (2010) (18)
Thrombosis in immune thrombocytopenia — current status and future perspectives (2021) (17)
Time for a hospital antacid policy on Clostridium difficile (2008) (17)
Transfusion-Related Acute Lung Injury — A Review (2009) (16)
Management of parturients with Factor XI deficiency-10year case series and review of literature. (2017) (16)
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP (2022) (16)
Deep vein thrombosis (2014) (16)
Thromboelastometry in critically ill patients with disseminated intravascular coagulation. (2019) (16)
The current status of viscoelastic testing in septic coagulopathy. (2019) (16)
Unsuspected pulmonary embolism (2010) (16)
D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients (2020) (15)
T‐regulatory cell response in psoriasis and changes with imatinib therapy (2009) (15)
Is Rituximab‐induced Late‐onset Neutropenia a good prognostic indicator in lymphoproliferatve disorders? (2011) (15)
Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation. (2016) (15)
Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH (2022) (14)
Nitric oxide in transplantation-related thrombotic microangiopathy (2009) (14)
Myelodysplastic syndrome with trisomy 8 associated with Behçet syndrome: An immunologic link to a karyotypic abnormality (2008) (14)
Nitric oxide in immune thrombocytopenic purpura (2009) (14)
Recurrent venous thromboembolism while on anticoagulant therapy. (2012) (13)
The problem of under-diagnosis and over-diagnosis of pulmonary embolism. (2019) (13)
Sickle cell disease and COVID‐19: Atypical presentations and favorable outcomes (2020) (13)
Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy (2021) (13)
DOACs and “newer” hemophilia therapies in COVID‐19: Reply (2020) (13)
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel (2020) (13)
Thrombotic thrombocytopenic purpura: is there more than ADAMTS‐13? (2007) (13)
Early Host Interactions That Drive the Dysregulated Response in Sepsis (2019) (13)
Nitric oxide and adverse events of vascular endothelial growth factor inhibitors (2011) (12)
Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim (2013) (12)
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis (2017) (12)
Platelets and infections in the resource‐limited countries with a focus on malaria and viral haemorrhagic fevers (2017) (12)
Addendum to the British Committee for Standards in Haematology (BCSH): Guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant, 2004 (Br. J Haematol 2004,126,11‐28) (2017) (12)
“Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH”: Reply (2021) (11)
Non‐myeloablative transplantation for severe congenital neutropenia (2008) (11)
Autoimmune haemolytic anaemia – an under‐recognized risk factor for venous thromboembolism (2008) (11)
Management of bleeding and procedures in patients on antiplatelet therapy. (2020) (11)
The problem of pulmonary embolism diagnosis in pregnancy (2015) (11)
Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency (2017) (11)
Physiological Levels of Pentraxin 3 and Albumin Attenuate Vascular Endothelial Cell Damage Induced by Histone H3 In Vitro (2016) (10)
Modified ISTH pregnancy-specific DIC score in parturients with liver rupture: population-based case series (2019) (10)
Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency (2017) (10)
Is this immune thrombocytopenic purpura? (2007) (10)
The enigma of pulmonary hypertension after splenectomy--does the megakaryocyte provide a clue? (2009) (10)
Interstitial pneumonitis--An important differential diagnosis for pulmonary sepsis in haematology patients. (2012) (10)
Addendum to the British Committee for Standards in Haematology (BCSH): guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant, 2004 (Br. J Haematol 2004,126,11‐28) ‐ response to Neisser‐Svae and Heger (2018) (10)
A level‐headed approach to measuring direct oral anticoagulants: A 2‐year retrospective analysis of DOAC levels from a tertiary UK centre (2018) (10)
Adverse effects of imatinib—Dissecting heart from the rest (2011) (10)
Whole Blood for Civilian Urban Trauma Resuscitation: Historical, Present, and Future Considerations (2020) (9)
Portal vein thrombosis – a primer for the general physician (2017) (9)
The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis. (2009) (9)
Emergency and out of hours care of patients with inherited bleeding disorders (2012) (9)
Harmonized guidance for disseminated intravascular coagulation from the International Society on Thrombosis and Haemostasis and the current status of anticoagulant therapy in Japan: a rebuttal (2013) (9)
Tamoxifen for recurrent bleeds due to angiodysplasia in von Willebrand's disease (2013) (9)
Similarities and perspectives on the two C’s—Cancer and COVID‐19 (2021) (9)
Thrombocytopenia with rituximab treatment—splenomegaly as the risk factor (2009) (9)
Lessons learnt from COVID‐19 coagulopathy (2021) (9)
Differentiating biochemical from clinical heparin resistance in COVID-19 (2020) (9)
Does perfusion equal diuresis in the upper urinary tract? (1983) (8)
Thrombotic thrombocytopenic purpura with the use of efalizumab for psoriasis (2008) (8)
DOACs and ‘newer’ haemophilia therapies in COVID-19 (2020) (8)
Inappropriateness of fresh frozen plasma for abnormal coagulation tests. (2012) (8)
Clinical differentiation of anticoagulant and non‐anticoagulant properties of heparin (2020) (8)
Is anticoagulating haemodialysis patients with non‐valvular atrial fibrillation too risky? (2018) (8)
The Comparison of the Protective Effects of α- and β-Antithrombin against Vascular Endothelial Cell Damage Induced by Histone in Vitro (2017) (8)
In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency (2016) (8)
Hairy cell leukaemia, negative for conventional cell markers, diagnosed using antibodies to Annexin A1 and T‐bet (2010) (8)
DIC in Pregnancy – Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments (2022) (8)
Membranous glomerulonephritis--an under-reported histological finding in multiple myeloma. (2009) (7)
Thrombocytopenia in the Intensive Care Unit (2014) (7)
Multisystem failure due to three coexisting autoimmune diseases. (2009) (7)
A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists (2018) (7)
Re‐emergence of a low‐titre factor VIII inhibitor after liver transplant (2012) (7)
Clinical implications of clotting screens (2015) (7)
Screening Strategies for Hemochromatosis (2009) (7)
Immature reticulocytes and its relevance to thrombosis (2008) (7)
Iron deficiency: still under-diagnosed? (2015) (7)
COVID-19 (SARS-CoV-2) in Non-Airborne body fluids: A systematic review & Meta-analysis. (2021) (7)
The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper (2019) (7)
Nitric oxide and the clinical manifestations of acute porphyria (2008) (7)
Abnormal coagulation tests before kidney biopsies—what next? (2013) (6)
Placental abruption as a trigger of DIC in women with HELLP syndrome: a population-based study (2020) (6)
Nitric oxide depletion is responsible for the adverse effects of vascular endothelial growth factor inhibitors (2008) (6)
Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood product transfusion (2020) (6)
Factor X deficiency presenting as a pseudotumor. Case report. (2006) (6)
The myths about platelet transfusions in immune‐mediated thrombocytopenias (2010) (6)
Disseminated Intravascular Coagulation: The Past, Present, and Future Considerations. (2022) (6)
Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH. (2017) (5)
Approach to the Diagnosis and Classification of Blood Cell Disorders (2016) (5)
Alternate considerations for current concepts in ITP (2014) (5)
Haematology in Critical Care: A Practical Handbook (2014) (5)
Direct oral anticoagulants: a practical guide for the emergency physician (2016) (5)
The application of anticoagulant therapy to sepsis (2017) (5)
Evaluation of Google Glass™ with Camera Adaptor and GoPro™ as Teaching Tools for Endotracheal Intubation in the Austere Medical Environment (2018) (5)
The difficult distinction between antiphospholipid syndrome and thrombotic thrombocytopenic purpura (2010) (5)
Causes of thrombotic thrombocytopenic purpura. (2007) (5)
Lessons from recurrent deep vein thrombosis in Glanzmann thrombasthenia (2013) (5)
Reintroduction of anticoagulant therapy after intracranial haemorrhage: If and when? (2017) (5)
A clue to the pathophysiology of posterior reversible encephalopathy syndrome. (2010) (5)
Does COVID-19 Provide a Clue for Thrombosis in ITP? (2021) (5)
Management of pregnancy in type 3 von Willebrand disease with alloantibodies (2018) (5)
Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective? (2016) (5)
Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia. (2012) (5)
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy (2021) (5)
Lessons from a survey of genotyping for hereditary haemochromatosis (2015) (4)
The malignant hypertension-thrombotic microangiopathy link. (2008) (4)
Depression in adult patients with primary immune thrombocytopenia (2016) (4)
Thrombotic Thrombocytopenic Purpura (2011) (4)
A practical approach to thrombophilia testing. (2013) (4)
Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers (2021) (4)
The beneficial effect of acute phase increase in serum ferritin. (2016) (4)
Example of the drug interaction between ciclosporin and orlistat, resulting in relapse of Evan's syndrome (2016) (4)
Iron physiology, iron overload, and the porphyrias (2016) (4)
Prothrombin complex concentrate to correct acquired abnormalities of the clotting screen in patients with liver impairment (2017) (4)
D-dimers-"Normal" Levels versus Elevated Levels Due to a Range of Conditions, Including "D-dimeritis," Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19. (2022) (4)
Coagulopathy of sepsis from nonspecific inhibitors (2015) (4)
A ploidy-agnostic method for estimating telomere length from whole genome sequencing data. (2018) (4)
Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients (2020) (4)
COVID-19 Vaccine-Induced Immune Thrombosis with Thrombocytopenia (VITT) and the Shades of Grey in Thrombus Formation (2021) (4)
The contribution of megakaryocytes to liver fibrosis (2009) (4)
Iliofemoral deep vein thrombosis and the problem of post-thrombotic syndrome. (2018) (4)
l-Asparaginase, nitric oxide and posterior reversible encephalopathy syndrome (2012) (4)
How do you decide on hormone replacement therapy in women with risk of venous thromboembolism? (2017) (4)
Managing sepsis‐associated coagulopathy remains an enigma (2019) (4)
The role for adjunctive treatment to plasma exchange in thrombotic thrombocytopenic purpura. (2008) (4)
Acquired haemophilia: an easy diagnosis to miss in a patient taking warfarin. (2015) (3)
Practical Treatment Guidance for Cancer-Associated Thrombosis - Managing the Challenging Patient: A Consensus Statement. (2022) (3)
Ligneous conjunctivitis with plasminogen deficiency (2009) (3)
Steroids and arteriovenous thrombosis: the role of underlying disease. (2013) (3)
A mystery unravels. (2007) (3)
Problem-Based Review: Non Vitamin K Antagonist Oral Anticoagulants for the Acute Physician. (2015) (3)
JAK2‐positive myeloproliferative neoplasm co‐existing with systemic mastocytosis (2011) (3)
Management of a myocardial infarction in a patient with classical acquired haemophilia patient in partial remission (2015) (3)
A review of anticoagulation in patients with central nervous system malignancy: between a rock and a hard place (2020) (3)
Iron metabolism, iron overload, and the porphyrias (2013) (3)
Dilemmas in management of suspected venous thromboembolism in the obese patient. (2016) (3)
Ventilation perfusion scan or computed tomography pulmonary angiography for the detection of pulmonary embolism? (2016) (3)
Heparin-Induced Thrombocytopenia in the Intensive Care Unit (2010) (3)
The authors reply. (2020) (3)
Thrombocytopenia in an adult (2013) (3)
Dispelling myths about coagulation abnormalities in internal medicine. (2014) (3)
Fondaparinux as Alternative Anticoagulant to Warfarin or Low-Molecular-Weight Heparin for Recurrent Venous Thrombosis (2014) (3)
Heparin induced thrombocytopenia with thrombosis: a two step process? (2008) (3)
Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH (2022) (3)
Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial (2020) (3)
Haemophilia stress fractures – an increasing complication with better orthopaedic care (2013) (3)
Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? (2021) (3)
Mixing studies for abnormal coagulation screen – the current trend (2017) (3)
You can bleed, you are on blood‐thinners! (2021) (3)
Dilemmas in the use of new oral anticoagulants. (2015) (3)
Erythropoietin corrects thrombocytopenia. (2013) (3)
The possible role of reticulocytes in sickle cell disease associated thromboembolism (2008) (3)
Surgical decision making around paediatric preoperative anaemia in low-income and middle-income countries. (2019) (2)
Non‐factor therapies for bleeding disorders: A primer for the general haematologist (2022) (2)
Reply to “Errors in the diagnosis for DIC due to a statistical misunderstanding” (2020) (2)
Anticoagulation in thrombocytopenic patients – Time to rethink? (2022) (2)
Do we need 'routine' blood counts? (2014) (2)
The ups and downs of anticoagulation prescription in the United Kingdom (2019) (2)
Two Factor XI Concentrates Correct Impaired Thrombin Generation in Major FXI Deficiency but Are Not Equivalent in Their Effect (2014) (2)
When deep vein thrombosis occurs in the upper limb. (2016) (2)
PFM.16 Third trimester amniocentesis for inherited bleeding disorders can be used to inform delivery management for at risk male fetuses (2014) (2)
Doctor, Do I Have Lupus? Time to Reconsider the Lupus Anticoagulant Terminology (2021) (2)
Exocrine Function of Testis with Germinal Testicular Tumour (1984) (2)
The problem with incidental and chronic portal vein thrombosis. (2017) (2)
Corrigendum to “Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia” [Leuk. Res. 36 (2012) 488–490] (2012) (2)
Extreme thrombocytosis--an unusual presentation of inflammatory bowel disease. (2008) (2)
Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020) (2)
Congenital absence of inferior vena cava: an overlooked cause of deep vein thrombosis. (2016) (2)
Anti-Xa based dose changes during low molecular weight heparin anticoagulation for mechanical prosthetic heart valves during pregnancy (2018) (2)
Campath-1H induced pure red cell aplasia in a patient with chronic lymphatic leukaemia. (2007) (2)
Why do thrombocytopenic patients bleed? (2013) (2)
Haemolysis secondary to intravenous immunoglobulins for ITP (2013) (2)
Faculty Opinions recommendation of Cardiovascular events and intensity of treatment in polycythemia vera. (2013) (2)
Can direct oral anticoagulants be used in kidney transplant recipients? (2021) (2)
Usefulness of Combining D-Dimers with Thromboelastography (2020) (2)
Is coagulopathy a contraindication for thromboprophylaxis? (2013) (2)
T cell function in chronic myeloid leukemia and its treatment with tyrosine kinase inhibitors--clues from and for sarcoidosis. (2009) (1)
Who should request and interpret tests for heritable thrombophilia? (2007) (1)
Practical management of the haemorrhagic complications of myeloproliferative neoplasms (2022) (1)
Chronic deep vein thrombosis. (2018) (1)
The relevance of the coagulation screen before surgery. (2017) (1)
Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia (2021) (1)
Are neutropenic patients at an increased risk of infection? (2012) (1)
Handbook of Venous Thromboembolism (2017) (1)
Investigating easy bruising in an adult (2017) (1)
Successful Treatment of Disseminated Fusariosis With Ocular Involvement After Chemotherapy for Secondary Acute Myeloid Leukemia (2010) (1)
Microangiopathic hemolytic anemia due to ADAMTS-13 loss in idiopathic systemic capillary leak syndrome. (2017) (1)
Warfarin Management in Practice (2015) (1)
A very elevated D-dimer level may potentially be useful. (2013) (1)
Acquired Coagulation Disorders (2010) (1)
The great imitator. Addison disease. (2010) (1)
The disappearing spleen. (2010) (1)
How long to anticoagulate? (2014) (1)
Myelofibrosis in ITP and with TPO-RA – time to rethink? (2020) (1)
Behcet's disease and refractory thrombosis. (2015) (1)
Contact Activation Inhibition and Platelet Rich Plasma Are Required in Order to Differentiate Bleeders from Non-Bleeders in FXI Deficiency Using the Thrombin Generation Assay (2014) (1)
[Urinary continence after radical prostatectomy: the urodynamic proof of an anatomical hypothesis (author's transl)]. (1976) (1)
Potential Clues to the Pathogenesis of Acquired Hemophilia (2021) (1)
Over-reliance of D-dimer in isolation to exclude venous thrombosis should be avoided. (2012) (1)
Has deep vein thrombosis become a new epidemic? (2014) (1)
Are white blood cells white? (2021) (1)
Expecting the unexpected: Acquired haemophilia A in a patient with homozygous factor V deficiency (2019) (1)
Nephrotic syndrome with spontaneous anticoagulant activity. (2006) (1)
Dual origins and dual roles for von Willebrand factor (2021) (1)
Similarities in coagulation for turophiles and clottologists (2021) (1)
Management of venous thromboembolism in athletes. (2020) (1)
Disseminated Intravascular Coagulation (2016) (1)
UK prescribing practice of anticoagulants in patients with chronic kidney disease: a nephrology and haematology-based survey (2023) (1)
Effect of diuresis and glucagon on upper urinary tract dynamics in the dog. (1985) (1)
Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020) (1)
Lipoproteins, statins and septic haematology patients (2011) (1)
Plasma dabigatran activity one week after discontinuation despite normal renal function. (2013) (1)
Phenotypic implications of a co-existent haemorrhagic and thrombotic genotype. (2012) (1)
Is it congenital or acquired von Willebrands disease? (2015) (1)
Disease activity and venous thromboembolism in inflammatory bowel disease (2010) (1)
Haematology in critical care (2015) (1)
Thromboprophylaxis in COVID-19 – Rationale and considerations (2021) (1)
Reduction of circulating histone toxicity is a major function of C-reactive protein after extensive tissue damage (2011) (1)
British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding (Br J Haematol. 2018;181:54–67). Addendum August 2020 (2020) (1)
Reactive oxygen species and mitogen-activated protein kinase activation in the development of Burkitt's lymphoma in Crohn disease. (2009) (1)
Relevance of clotting screen requests. (2014) (1)
Management of blood transfusion services in low‐resource countries (2022) (1)
Why “the Love of Blood” in Hemophilia? (2021) (1)
What is the evidence for platelet transfusion thresholds? (2014) (1)
Long Term Eltrombopag in Paediatric Immune Thrombocytopenia: Update on UK Patients Treated with Eltrombopag As Part of the Petit and PETIT2 Studies (2017) (1)
A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease (2022) (1)
Can patients with pulmonary embolism be managed as an outpatient? (2016) (1)
Dilemmas in the management of venous thromboembolism in older patients. (2017) (1)
The misconceptions about warfarin. (2011) (1)
Thrombocytopenia and thromboprophylaxis: a difficult combination? (2013) (0)
Extreme warfarin hypersensitivity after oophorectomy. (2015) (0)
Disseminated Intravascular Coagulation in Pregnancy: Insights in Pathophysiology, Diagnosis, and Management (2016) (0)
The difficult distinction between haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura (2008) (0)
Clopidogrel resistance in stroke patients (The CRISP Trial) (2014) (0)
How to optimise anticoagulation for patients who are obese. (2020) (0)
Working report on Clot Waveform Analysis Towards standardization and recommendations for clot waveform analysis (2012) (0)
Monocyte Recruitment and Arthroplasty: Primary and Revision (2013) (0)
Autoimmune haemolytic anaemia for the non-specialist. (2014) (0)
Getting the anticoagulation right in the intensive care (2014) (0)
Dilemmas in hematology: consults in patients with arterial thrombosis. (2023) (0)
Thromboprophylaxis in Orthopaedics (2016) (0)
Splenomegaly in the tropics (2014) (0)
Reclassifying hemophilia to include definition of outcomes and phenotype as new targets. (2023) (0)
Management of haemostatic complications of chimaeric antigen receptor T‐cell therapy (2022) (0)
Providing accurate information to patients who develop deep vein thrombosis. (2013) (0)
Thromboprophylaxis in gynaecology: a review of current evidence (2023) (0)
Duration of anticoagulation: the decision-making process. (2015) (0)
The authors reply (2020) (0)
Faculty Opinions recommendation of VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. (2014) (0)
[Surgery of endocrine hyperfunctional state of suprarenal glands]. (1975) (0)
Reduced elimination of Methotrexate in an adult with trisomy 21 and acute lymphoblastic leukaemia. (2007) (0)
Why do patients with DIC bleed? (2021) (0)
The platelet-skin connection (2022) (0)
Spondylodiscitis from infection of central venous line inserted for haemophilia prophylaxis (2011) (0)
What happens after prothrombin complex concentrate administration? (2013) (0)
Ovarian malignancy revealed by anticoagulation. (2015) (0)
Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasias on vascular endothelium-related biomarkers in disseminated intravascular coagulation. (2022) (0)
Timing is crucial when considering antiplatelet therapy for trauma. (2013) (0)
Clotting Screen Requests in Pediatrics (2012) (0)
Faculty Opinions recommendation of Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. (2013) (0)
Perioperative management of patients on new oral anticoagulants (2014) (0)
Embolism—The journey from a calendar to the clot via the Lord’s prayer (2022) (0)
Deciding on a combination of anticoagulant and antiplatelet drugs. (2015) (0)
Hemostasis in tweeters (2021) (0)
The underdiagnosis of pulmonary hypertension in myelofibrosis. (2010) (0)
The patient with anaemia (2014) (0)
To Bleed or Not to Bleed: Correcting Deranged Coagulation and Thrombocytopenia Prior to Transjugular Liver Biopsies: 489 (2013) (0)
DIC score predicts mortality in massive clot coagulopathy as a result of extensive pulmonary embolism: a rebuttal (2010) (0)
Faculty Opinions recommendation of Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. (2013) (0)
Will direct oral anticoagulants completely replace warfarin? (2018) (0)
Anemia as a potential contributor to bleeding in patients with liver disease - Neglected but not forgotten (2011) (0)
Haemoglobinopathies and red cell enzymopathies (2014) (0)
Blood coagulation and beyond: Position paper from the Fourth Maastricht Consensus Conference on Thrombosis. (2023) (0)
The diagnosis of recurrent venous thrombosis--can a risk stratified approach at initial presentation be helpful? (2008) (0)
Thrombosis with inflammatory bowel disease--bleed, clot or break. (2012) (0)
New Insights on the Pathogenesis and Treatment of Crystal Arthritis (2013) (0)
Faculty Opinions recommendation of P-selectin promotes neutrophil extracellular trap formation in mice. (2015) (0)
Difficult transition from a new oral anticoagulant to parenteral anticoagulant in an overweight female (2015) (0)
Iron deficiency: still under-diagnosed? Anaemia resulting from iron deficiency is one of the commonest diseases affecting humankind. Although its diagnosis and management may be straightforward, iron deficiency is underdiagnosed in nations with structured health-care systems, mainly because of a lac (2015) (0)
Rotational thromboelastometry in critically ill COVID‐19 patients does not predict thrombosis (2022) (0)
A survey of platelet aggregometry tests in a tertiary centre (2016) (0)
Faculty Opinions recommendation of Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. (2012) (0)
proplatelet formation causing thrombocytopenia Sphingolipid dysregulation due to lack of functional KDSR impairs Version 3 HAEMATOL / 2018 / 204784 (2019) (0)
Is protein C zymogen really ineffective for ALL cases of sepsis including septic DIC? (2016) (0)
Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis. (2023) (0)
Could bloodletting have helped? (2021) (0)
Transferrin saturation in hemochromatosis: is there still a role? (2008) (0)
A case of benign, multiple metastases. (2011) (0)
The implications of aspirin resistance in renal failure (2008) (0)
Reduced Intensity Conditioning Matched Unrelated Donor Allograft for Kostmann Syndrome. (2005) (0)
Inpatient or Outpatient Anticoagulation (2017) (0)
Primary radiotherapy for childhood ependymoma (2007) (0)
Publisher Correction: Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data (2018) (0)
Lessons from an incidental diagnosis of paroxysmal nocturnal haemoglobinuria (2012) (0)
POS-472 THROMBOEMBOLISM IN PRIMARY NEPHROTIC SYNDROME (2022) (0)
Challenges in managing patients on anticoagulation: Thrombocytopenia, resumption after bleeding and recurrent thrombosis (2022) (0)
SP768RISK OF ALLOGRAFT THROMBOSIS AND USE OF THROMBOPHILIA SCREEN IN HIGH RISK KIDNEY TRANSPLANT RECIPIENTS (KTRS) -A SINGLE CENTRE EXPERIENCE (2017) (0)
D-dimers: a most misunderstood test. (2021) (0)
Recurrent thrombosis despite a therapeutic international normalised ratio. (2013) (0)
Haematological diseases in the tropics. Chapter 65. (2013) (0)
Re: half of visible and half of recurrent visible hematuria cases have underlying pathology: prospective large cohort study with long-term followup: S. F. Mishriki, R. Vint and B. K. Somani J Urol 2012;187:1561-1565. (2013) (0)
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data (2018) (0)
What should we do when a small pulmonary embolus is diagnosed unexpectedly? (2018) (0)
Risk of venous thromboembolism in pregnancy and risks from unnecessary investigations must both be minimised (2013) (0)
Platelet kinetics in patients with chronic immune thrombocytopaenia treated with thrombopoietin receptor agonists (2023) (0)
Sub‐segmental and Incidental PE – to Treat or Not? (2017) (0)
RE: The prothrombin time ratio is not a more effective marker for evaluating sepsis‐induced coagulopathy than fibrin‐related markers: Response to the Letter‐to‐the‐Editor by Dr Wada (2020) (0)
The problem with coagulopathy … (2022) (0)
Osteoarthritis: Modification of the Inflammatory Response in Obese Patients by NSAIDs (2013) (0)
History of the word “purpura” and its current relevance (2021) (0)
Corrigendum: Portal vein thrombosis - a primer for the general physician. (2017) (0)
Communication from the SSC of the ISTH on vascular endothelium-related biomarkers in DIC (2022) (0)
Pre-eclampsia is an inflammatory disorder (2007) (0)
Exploring the epidemiology of disseminated intravascular coagulation: protocol for the DANish Disseminated Intravascular Coagulation (DANDIC) Cohort Study (2022) (0)
Reticulocytes and erythroid precursors in haemolysis vasculopathy (2010) (0)
D-Dimer and thrombosis in COVID-19 (2021) (0)
The Abnormal Clotting Profile (2014) (0)
Deep Vein Thrombosis is Common After Cardiac Ablation and Pre-Procedural D-Dimer Could Predict Risk. (2022) (0)
Should low molecular weight heparin dosing be based on anti-Xa assays in antiphospholipid syndrome? (2013) (0)
Microangiopathic hemolytic anemia due to ADAMTS‐13 loss in idiopathic systemic capillary leak syndrome: comment (2017) (0)
Is NOAC without monitoring as good as warfarin? (2016) (0)
The relation between fibrinogen level, neutrophil activity and nucleosomes in the onset of disseminated intravascular coagulation in the critically ill (2021) (0)
Venous Thromboembolism in Intensive Care (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jecko V. Thachil?

Jecko V. Thachil is affiliated with the following schools:

University of Liverpool
Manchester University